Serum IgA levels induced by rotavirus natural infection, but not following immunization with the RRV-TV vaccine (Rotashield™), correlate with protection

被引:15
作者
González, R
Franco, M
Sarmiento, L
Romero, M
Schael, IP
机构
[1] Cent Univ Venezuela, Inst Biomed Fuvesin, Secc Invest Enfermedades Entericas Infancia, Minist Salud & Desarrollo Social, Caracas 1010A, Venezuela
[2] Pontificia Univ Javeriana, Inst Genet Humana, Bogota, Colombia
[3] Cent Univ Venezuela, Inst Inmunol, Postgrado Inmunol Clin, Minist Salud & Desarrollo Social, Caracas 1010A, Venezuela
[4] Ciudad Hosp Dr Enrique Tejera CHET, Valencia, Estado Carabobo, Venezuela
基金
英国医学研究理事会;
关键词
diarrhea; immune response;
D O I
10.1002/jmv.20404
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To directly compare serum rotavirus specific IgA as a marker of protection in children vaccinated with the RRV-TV (Rotashield (TM)) vaccine and in naturally infected children, we studied preexisting rotavirus IgA antibodies by ELISA assays in these groups of children within the first 5 days after the onset of a diarrhea episode, due or not to rotavirus. In immunized children, rotavirus IgA titers were similar between infected and non-RV infected children. In non-immunized children, the proportion with rotavirus IgA titers was significantly greater in non-RV infected children (58%) than in infected children (31%). Additionally, a titer >= 1:800 was associated with 68% protection. Thus, in this study serum rotavirus IgA showed a good correlation with protection in children pre-exposed to natural infection but not in those immunized with the RRV-TV vaccine. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:608 / 612
页数:5
相关论文
共 26 条
  • [21] Rotavirus infection in infants as protection against subsequent infections
    Velazquez, FR
    Matson, DO
    Calva, JJ
    Guerrero, ML
    Morrow, AL
    CarterCampbell, S
    Glass, RI
    Estes, MK
    Pickering, LK
    RuizPalacios, GM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1022 - 1028
  • [22] Serum antibody as a marker of protection against natural rotavirus infection and disease
    Velázquez, FR
    Matson, DO
    Guerrero, ML
    Shults, J
    Calva, JJ
    Morrow, AL
    Glass, RI
    Pickering, LK
    Ruiz-Palacios, GM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) : 1602 - 1609
  • [23] CLINICAL EFFICACY OF THE RIT-4237 LIVE ATTENUATED BOVINE ROTAVIRUS VACCINE IN INFANTS VACCINATED BEFORE A ROTAVIRUS EPIDEMIC
    VESIKARI, T
    ISOLAURI, E
    DELEM, A
    DHONDT, E
    ANDRE, FE
    BEARDS, GM
    FLEWETT, TH
    [J]. JOURNAL OF PEDIATRICS, 1985, 107 (02) : 189 - 194
  • [24] Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model
    Ward, RL
    [J]. VIRAL IMMUNOLOGY, 2003, 16 (01) : 17 - 24
  • [25] LACK OF CORRELATION BETWEEN SERUM ROTAVIRUS ANTIBODY-TITERS AND PROTECTION FOLLOWING VACCINATION WITH REASSORTANT RRV VACCINES
    WARD, RL
    BERNSTEIN, DI
    [J]. VACCINE, 1995, 13 (13) : 1226 - 1232
  • [26] Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial
    Ward, RL
    Knowlton, DR
    Zito, ET
    Davidson, BL
    Rappaport, R
    Mack, ME
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (03) : 570 - 577